Century Therapeutics Inc. (NASDAQ: IPSC) Stock Information | RedChip

Century Therapeutics Inc. (NASDAQ: IPSC)


$1.0550
-0.0450 ( -4.96% ) 183.6K

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Market Data


Open


$1.0550

Previous close


$1.1000

Volume


183.6K

Market cap


$87.58M

Day range


$1.0250 - $1.1800

52 week range


$0.9800 - $5.5100

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Sep 26, 2024
4 Insider transactions 1 Sep 16, 2024
10-q Quarterly Reports 96 Aug 08, 2024
8-k 8K-related 49 Aug 08, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Aug 07, 2024
4 Insider transactions 1 Jul 31, 2024
4 Insider transactions 1 Jul 25, 2024
8-k 8K-related 47 Jul 08, 2024
8-k/a 8K-related 19 Jun 26, 2024

Latest News